Source-grounded facts extracted from Seer, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Seer, Inc.: Adoption of Certificate of Designation for Series A Participating Preferred Stock (effective 2026-02-26).
“the Board approved a Certificate of Designation of Rights, Powers and Preferences of Series A Participating Preferred Stock (the “Certificate of Designation”) setting forth the rights, powers and preferences of the Preferred Stock. The Certificate of Designation will be filed with the Secretary of State of the State of Delaware to be effective on February 26, 2026.”
Seer, Inc.: Filed Certificate of Retirement to reduce authorized shares of capital stock and Class B Common Stock following automatic conversion of Class B to Class A shares (effective 2025-12-12).
“on December 12, 2025, the Company filed the Certificate of Retirement with the Secretary of State of the State of Delaware in connection with the retirement of the shares of Class B Common Stock that were issued but not outstanding following the Conversion and to accordingly reduce the Company's total number of authorized shares of capital stock and the Company's total number of authorized shares of Class B Common Stock by an amount equal to the number of retired shares of Class B Common Stock.”
Seer, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).
“July 7, 2025, Seer, Inc. (the "Company") notified The Nasdaq Stock Market LLC (“Nasdaq”) that following the Company's 2025 Annual Meeting of Stockholders (the "Annual Meeting"), the Company will no longer be in compliance with the Nasdaq Listing Rule 5605(c)(2)(A), which requires that (i) the Audit Committee of the Company's Board of Directors (the “Audit Committee”) be composed of at least three members, and (ii) that one member of the Audit Committee has past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience”
David Hallal changed role as Lead Independent Director at Seer, Inc..
“The Company also announced that Dr. Roelofs would replace David Hallal as the Company’s Lead Independent Director and would serve on the Company’s Corporate Governance and Nominating Committee and Science and Technology Committee.”
Nicolas Henry Roelofs was appointed as Lead Independent Director at Seer, Inc..
“On August 13, 2024, the board of directors (the “Board”) of Seer, Inc. (the “Company”) appointed Nicolas Henry Roelofs, Ph.D. to the Board with a term expiring at the Company’s 2025 annual meeting of the stockholders.”
Elona Kogan resigned as Chief Legal Officer and Corporate Secretary at Seer, Inc..
“On July 16, 2024, Elona Kogan resigned as the Chief Legal Officer and Corporate Secretary of Seer, Inc. (the “Company”), to pursue other career opportunities.”
Rachel Haurwitz resigned as Member of the Board of Directors at Seer, Inc..
“On July 8, 2024, Rachel Haurwitz, Ph.D. informed Seer, Inc. (the “Company”) of her resignation as a member of the Company’s Board of Directors (the “Board”) and all committees thereof, effective immediately”
Seer, Inc. reported the first quarter ended March 31, 2024 results: revenue $3.1 million. Guidance reaffirmed.
“commercializing a disruptive new platform for proteomics, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights • Achieved revenue of $3.1 million for the first quarter of 2024 • Announced the expansion of the Seer Technology Access Center (STAC) program to Europe, providing researchers with end-to-end services from sample”
Seer, Inc. reported the year ended December 31, 2023 results: revenue $16.7 million, net income $86.3 million. Guidance initiated.
“and full year ended December 31, 2023. Recent Highlights • Achieved revenue of $4.4 million for the fourth quarter of 2023, a decrease of 4% over the fourth quarter of 2022, and $16.7 million for the full year 2023, an increase of 8% over the full year 2022 • Shipped 23 instruments during 2023, bringing cumulative instruments shipped to 62 as of December 31, 2023 •”
Seer, Inc. reported the quarter ended December 31, 2023 results: revenue $4.4 million, net income $17.8 million. Guidance initiated.
“a disruptive new platform for proteomics, today reported financial results for the fourth quarter and full year ended December 31, 2023. Recent Highlights • Achieved revenue of $4.4 million for the fourth quarter of 2023, a decrease of 4% over the fourth quarter of 2022, and $16.7 million for the full year 2023, an increase of 8% over the full year 2022 • Shipped 23”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.